Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis

Status Recruiting

Clinical Trial Summary

The objective of this study is to evaluate the efficacy and safety of accelerated cross-linking (Avedro Inc., Waltham, USA) in the management of microbial keratitis as adjunctive therapy.

Clinical Trial Description

Investigators perform a comprehensive ophthalmological examination, including evaluation of risk factors (immunosuppressive status, ocular trauma, previous ocular surgery, contact lens wear, topical corticosteroids use), best-corrected visual acuity (Snellen chart), slit-lamp biomicroscopy, tonometry and fundoscopy. In addition, anterior segment optical coherence tomography imaging (Visante, Carl Zeiss Meditec, Dublin, California, USA), corneal scrapes, culture and clinical photographs at day 1, day 7, month 1 and 3 will be analyzed.

Each participant will be assigned to one of four groups after randomization. Group 1: Initial ulcer on treatment with antibiotic plus sham (n = 66), these partcipants will receive only topical moxifloxacin 0,5% (Vigamoxi, Alcon, Texas, USA) and sham CXL; Group 2: Initial ulcer on treatment with antibiotic plus cross-linking (CXL) (n = 66) receive moxifloxacin plus CXL (riboflavin 0.1% during 10 minutes and irradiation 30 mW/cm2 during 3 minutes using accelerated CXL); Group 3: Refractory corneal ulcer on treatment with antibiotic plus sham (n=66), receive only topical antibiotic plus sham CXL; Group 4: Refractory corneal ulcer on treatment with antibiotic plus CXL will receive their standard medications plus CXL.

Statistical analysis will be divided into four phases: 1) Analysis of compliance, 2) Intention to treat, 3) Losses to follow-up and 4) Variable-response (healing) using Stata/MP 12.0 (Stata Corp., College Station, TX). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02865876
Study type	Interventional
Source	Instituto de Oftalmología Fundación Conde de Valenciana
Contact	Lucero Pedro-Aguilar, MD
Phone	+5255880000
Email	lu.pedroaguilar@gmail.com
Status	Recruiting
Phase	Phase 3
Start date	June 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00513734` - A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill	N/A
Enrolling by invitation	`NCT03436576` - Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye	Phase 3
Recruiting	`NCT06229379` - The Effects of a Large Language Model on Clinical Questioning Skills	N/A
Completed	`NCT01268306` - Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses	Phase 4
Completed	`NCT01028027` - Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis	Phase 3
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Completed	`NCT04169061` - Impact of Acthar on Everyday Life of Participants With Severe Keratitis	Phase 4
Completed	`NCT03237936` - Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis	Phase 4
Completed	`NCT00001734` - Screening for NEI Clinical Studies	N/A
Recruiting	`NCT05255016` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers	Phase 2/Phase 3
Recruiting	`NCT05255107` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers	Phase 2/Phase 3
Terminated	`NCT05250583` - Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis	Phase 2
Terminated	`NCT02116062` - Robotic Surgery of the Ocular Surface	N/A
Recruiting	`NCT00838422` - Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound	N/A
Completed	`NCT00949468` - Microbiological Keratitis in a Countryside City of Brazil	N/A
Completed	`NCT03586505` - Tolerance to Light for Patients Suffering From Keratitis	N/A
Recruiting	`NCT04420962` - Automated Quantitative Ulcer Analysis Study
Completed	`NCT02186431` - Contact Lenses and Infiltrative Keratitis	N/A
Completed	`NCT05538793` - Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
Not yet recruiting	`NCT05689996` - Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis	Phase 3